Riskpilot← Back to searchSign inGet full accessKCI MEDICAL ApS
APSActiveCVR 18777045Kay Fiskers Plads 10Wholesale of pharmaceutical and medical goods · NACE 4646Est. 199520 employeeswww.solventum.com
Revenue 2024
DKK 33,7M
+517% vs 2023
EBITDA margin
51.7%
+516% vs 2023
Equity ratio
78.0%
Financial strength
Net profit 2024
DKK 3,2M
+380% vs 2023
| Revenue | DKK 33,7M | +517% |
| EBITDA | DKK 17,4M | +516% |
| Net profit | DKK 3,2M | +380% |
| Total assets | DKK 124,5M | +6% |
| Equity | DKK 97,1M | +3% |
| Employees | 20 | — |
Legal name
KCI MEDICAL ApS
CVR number
18777045
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
1. september 1995
Share capital
DKK 4.001.000
Employees
20 (FTE)
VAT registered
Yes
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør eller af den samlede direktion
Company purpose
Selskabets formål er at markedsføre og sælge medicinaludstyr, medicinalteknologi og tjenesteydelser på disse områder, eje aktier i andre selskaber og drive anden i forbindelse hermed stående virksomhed.
Address
Kay Fiskers Plads 10
Phone
+4532750107
Website
www.solventum.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | -162 | -147 | -457 | 5.458 | 33.694 |
| Staff expenses | -0 | -0 | -0 | -2.630 | -16.291 |
| EBITDA | -162 | -147 | -457 | 2.827 | 17.403 |
| Depreciation & amort. | -0 | -0 | -0 | -2.164 | -12.988 |
| EBIT | -162 | -147 | -457 | 663 | 4.415 |
| Net financials | -1 | -0 | 31 | 180 | -216 |
| Profit before tax | -162 | -147 | -426 | 843 | 4.199 |
| Tax | -0 | -0 | -94 | 186 | 1.048 |
| Net profit | -162 | -147 | -332 | 656 | 3.150 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 7.069 | 6.752 | 6.309 | 117.026 | 124.495 |
| Equity | 6.774 | 6.627 | 6.295 | 93.951 | 97.102 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 296 | 125 | 14 | 23.063 | 27.392 |
| Total debt | 296 | 125 | 14 | 23.063 | 27.392 |
EBITDA margin
51.7%
This company
15.8%
Market median
+227% vs market
20202024
Equity ratio
78.0%
This company
38.2%
Market median
+104% vs market
20202024
Return on equity
3.2%
This company
18.4%
Market median
-83% vs market
20202024
Net profit margin
9.4%
This company
8.1%
Market median
+16% vs market
20202024
Asset turnover
0.27×
This company
1.12×
Market median
-76% vs market
20202024
Debt / equity
0.28×
This company
0.62×
Market median
+55% vs market
20202024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
AH Management | Management | 2024 |
| Former (9) | ||
JM Management | Management | 1995 – 2002 |
ET | Audit | 1995 – 1995 |
TM Management | Management | 2022 – 2024 |
US Chief Executive Officer | Chief Executive Officer | 2010 – 2012 |
ME Chief Executive Officer | Chief Executive Officer | 2012 – 2014 |
BK Chief Executive Officer | Chief Executive Officer | 2002 – 2008 |
WJ Chief Executive Officer | Chief Executive Officer | 2008 – 2008 |
AN Chief Executive Officer | Chief Executive Officer | 2008 – 2010 |
PE Management | Management | 1995 – 1995 |
| Name | Role | Member since |
|---|---|---|
| Former (33) | ||
| Board of Directors | 2005 – 2008 | |
| Chairman | 2019 – 2020 | |
| Board of Directors | 2012 – 2014 | |
| Chairman | 2013 – 2015 | |
| Chairman | 2016 – 2017 | |
| Board of Directors | 2007 – 2008 | |
| Chairman | 1995 – 1995 | |
| Board of Directors | 2005 – 2007 | |
| Board of Directors | 2008 – 2009 | |
| Chairman | 2022 – 2024 | |
| Board of Directors | 2008 – 2010 | |
| Board of Directors | 2002 – 2005 | |
| Board of Directors | 2014 – 2019 | |
| Chairman | 2021 – 2022 | |
| Board of Directors | 2005 – 2007 | |
| Board of Directors | 2012 – 2012 | |
| Board of Directors | 2017 – 2019 | |
| Board of Directors | 2001 – 2002 | |
| Chairman | 2002 – 2005 | |
| Board of Directors | 2019 – 2020 | |
| Board of Directors | 2011 – 2012 | |
| Chairman | 1995 – 2002 | |
| Board of Directors | 2010 – 2012 | |
| Chairman | 2019 – 2019 | |
| Board of Directors | 2020 – 2022 | |
| Chairman | 2015 – 2016 | |
| Chairman | 2017 – 2019 | |
| Board of Directors | 2007 – 2008 | |
| Board of Directors | 1995 – 2010 | |
| Chairman | 2020 – 2021 | |
| Board of Directors | 2009 – 2010 | |
| Board of Directors | 1995 – 1995 | |
| Board of Directors | 2010 – 2015 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100% | 100% | 2007 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of KCI MEDICAL ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Jan Michael Solow | Management | 0 companies |
| Erik Tronborg Andersen | Audit | 0 companies |
| Tina Monk | Management | 0 companies |
| Anders Houmøller Bødker | Management | 0 companies |
| Ulf Sigurd Skimmeland | Chief Executive Officer | 0 companies |
| Michael Edward Mathews | Chief Executive Officer | 0 companies |
| Birgit Kirstine Ölmestig | Chief Executive Officer | 0 companies |
| William John David Burns | Chief Executive Officer | 0 companies |
| Anne-Mette Nansen Scherfig | Chief Executive Officer | 0 companies |
| Per Emil Hasselbalch Stakemann | Management | 0 companies |
| Stephen Dale Seidel | Board of Directors | 0 companies |
| Simla Semerciyan | Chairman | 0 companies |
| Flemming Toubro | Board of Directors | 0 companies |
| Peter Franciscus Bernardus Nijhuis | Chairman | 0 companies |
| Laura Piccinini | Chairman | 0 companies |
| Diana Jolanda Albertina Ferro | Board of Directors | 0 companies |
| Ulf Svejgaard Poulsen | Chairman | 0 companies |
| Jörg Wilhelm Menten | Board of Directors | 0 companies |
| Jason Rush Cone | Board of Directors | 0 companies |
| Lone Lehmann Laurberg | Chairman | 0 companies |
| Tirunvelveli Lakshmanaswamy Varadaraj Kumar | Board of Directors | 0 companies |
| Diana Jolande Albertina Ferro | Board of Directors | 0 companies |
| John Patrick Panther | Board of Directors | 0 companies |
| David James Ashley | Chairman | 0 companies |
| Antoine Lesage | Board of Directors | 0 companies |
| Stephen Dale Seidel | Board of Directors | 0 companies |
| Peter Robert Rhodes | Board of Directors | 0 companies |
| Jörg Wilhelm Menten | Board of Directors | 0 companies |
| Dennis Edward Noll | Chairman | 0 companies |
| Irfan Malik Mohammad | Board of Directors | 0 companies |
| Dirk Joachim Steindorf | Board of Directors | 0 companies |
| Frank Dilazzaro | Chairman | 0 companies |
| Rohit Shrikant Kashyap | Board of Directors | 0 companies |
| Hauke Sigurd Walter Wörtler | Chairman | 0 companies |
| Jonathan Robert Lasparini | Board of Directors | 0 companies |
| Adriano Cito | Chairman | 0 companies |
| Andrea Dobai-Kozak | Chairman | 0 companies |
| Lynne Denise Sly | Board of Directors | 0 companies |
| Michael Anthony John Holvey | Board of Directors | 0 companies |
| Stephen Fraser Evans | Chairman | 0 companies |
| Arthur Alejandro Perez | Board of Directors | 0 companies |
| Hans Christian Galst | Board of Directors | 0 companies |
| John Thomas Bibb | Board of Directors | 0 companies |